Keyword → SYK

Medtronic Posts Strongest Revenue Growth in Ten Quarters, Reiterates Full-Year Outlook

Medtronic reported third-quarter fiscal 2026 revenue of $9.02 billion, an 8.7% year-over-year increase representing the company's highest enterprise revenue growth in ten quarters, beating analyst estimates of $8.89 billion. Non-GAAP diluted EPS of $1.36 beat consensus by three cents, and the medical device giant reiterated full-year organic revenue growth guidance of approximately 5.5% despite a projected $185 million tariff headwind.

OPKO Health Schedules Q4 Earnings Report, Shares React to Upcoming Guidance

OPKO Health announced plans to release its fourth-quarter and full-year 2025 financial results later this month, expected to include commentary on future revenue and profitability. The upcoming earnings call could influence sentiment among healthcare and biotech investors amid broader market volatility.

Philips Reports 2025 Results With Margin Expansion and 2026 Outlook Targets

Royal Philips published its full-year 2025 financial results, highlighting accelerated growth, expanding profit margins and robust cash flow. The company also unveiled strategic targets for 2026-2028, emphasizing innovation and operational efficiency across health technology segments.